Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Palmqvist

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
JAMA|January 23, 2025
Blood Biomarkers to Detect Alzheimer Disease-ReplySebastian Palmqvist, Oskar Hansson
Neurology|December 2, 2020
Spatial Distribution of Tau and β-Amyloid Pathologies and Their Role in Different Alzheimer Disease PhenotypesSebastian Palmqvist, Arman Eshaghi
Brain : a Journal of Neurology|April 5, 2023
The emerging era of staging Alzheimer's disease pathology using plasma biomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist
Brain : a Journal of Neurology|July 8, 2016
Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson
Brain : a Journal of Neurology|March 4, 2016
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomographySebastian Palmqvist, Niklas Mattsson, Oskar Hansson, et al.
International Journal of Geriatric Psychiatry|April 7, 2009
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive testsSebastian Palmqvist, Oskar Hansson, Lennart Minthon, et al.
Dementia and Geriatric Cognitive Disorders Extra|May 21, 2013
Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's diseaseJoakim Hertze, Sebastian Palmqvist, Lennart Minthon, et al.
American Journal of Alzheimer'S Disease and Other Dementias|October 29, 2008
The usefulness of cube copying for evaluating treatment of Alzheimer's diseaseSebastian Palmqvist, Oskar Hansson, Lennart Minthon, et al.
Lakartidningen|July 10, 2009
[Lewy body dementia--big risk of wrong treatment and death]Fredrik Boström, Sebastian Palmqvist, Maria Andersson, et al.
Nature Communications|January 5, 2021
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studiesNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, et al.
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
JAMA|January 23, 2025
Blood Biomarkers to Detect Alzheimer Disease-ReplySebastian Palmqvist, Oskar Hansson
Neurology|December 2, 2020
Spatial Distribution of Tau and β-Amyloid Pathologies and Their Role in Different Alzheimer Disease PhenotypesSebastian Palmqvist, Arman Eshaghi
Brain : a Journal of Neurology|April 5, 2023
The emerging era of staging Alzheimer's disease pathology using plasma biomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist
Brain : a Journal of Neurology|July 8, 2016
Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson
Brain : a Journal of Neurology|March 4, 2016
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomographySebastian Palmqvist, Niklas Mattsson, Oskar Hansson, et al.
International Journal of Geriatric Psychiatry|April 7, 2009
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive testsSebastian Palmqvist, Oskar Hansson, Lennart Minthon, et al.
Dementia and Geriatric Cognitive Disorders Extra|May 21, 2013
Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's diseaseJoakim Hertze, Sebastian Palmqvist, Lennart Minthon, et al.
American Journal of Alzheimer'S Disease and Other Dementias|October 29, 2008
The usefulness of cube copying for evaluating treatment of Alzheimer's diseaseSebastian Palmqvist, Oskar Hansson, Lennart Minthon, et al.
Lakartidningen|July 10, 2009
[Lewy body dementia--big risk of wrong treatment and death]Fredrik Boström, Sebastian Palmqvist, Maria Andersson, et al.
Nature Communications|January 5, 2021
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studiesNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, et al.
Pageof 26